Each unit consists of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share. When trading begins on March 18, the ordinary shares and Series A Warrants will trade separately on the Nasdaq Capital Market under the symbols “CHEK” and “CHEKW” respectively.
Check-Cap is a clinical stage medical diagnostics company focused on the development of gastrointestinal imaging devices, including a preparation-free ingestible imaging capsule.
More articles on GI/endoscopy:
The Endoscopy Center to sign pledge for increasing CRC screening rates nationwide
Olympus faces 5 lawsuits in wake of UCLA outbreak
Dr. Daniel Podolsky to join Agilent Technologies board of directors
